Evidence map›Paper›PMID 42035466›Full record

ArticleInternational journal of methods in psychiatric research2026

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Kurt Stocker, Matthias Hartmann, Frederick S Barrett, William A Richards, Nathan D Sepeda, Laura Ley, Anna M Becker, Friederike Holze, Matthias E Liechti

Abstract readValidation StudyComparative Study
In one paragraph

Article in International journal of methods in psychiatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kurt StockerDepartment of Clinical Research, Division of Clinical Pharmacology & Toxicology, Psychopharmacology Research, University Hospital Basel, and University of Basel, Basel, Switzerland.ORCID 0000-0002-6161-7114
Matthias HartmannFaculty of Psychology, UniDistance Suisse, Brig, Switzerland.
Frederick S BarrettDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
William A RichardsDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Nathan D SepedaDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Laura LeyDepartment of Clinical Research, Division of Clinical Pharmacology & Toxicology, Psychopharmacology Research, University Hospital Basel, and University of Basel, Basel, Switzerland.
Anna M BeckerDepartment of Clinical Research, Division of Clinical Pharmacology & Toxicology, Psychopharmacology Research, University Hospital Basel, and University of Basel, Basel, Switzerland.
Friederike HolzeDepartment of Clinical Research, Division of Clinical Pharmacology & Toxicology, Psychopharmacology Research, University Hospital Basel, and University of Basel, Basel, Switzerland.ORCID 0000-0003-3143-1519
Matthias E LiechtiDepartment of Clinical Research, Division of Clinical Pharmacology & Toxicology, Psychopharmacology Research, University Hospital Basel, and University of Basel, Basel, Switzerland.ORCID 0000-0002-1765-9659

Funding

by Dr. Botond Berde-Fonds/Freiwillige Akademische Gesellschaft Basel, SwitzerlandSteven and Alexandra Cohen Foundation
6 · The paper itself

Abstract

objectivesFor English, the validated part of Psychedelic Experience Scale (PES48) is a four-factor structure called the Mystical Experience Questionnaire (MEQ30). The other validated part of the PES48 consists of four more factors: two more mystical factors (paradoxicality and connectedness, which together with the MEQ30 form the MEQ40), and two more non-mystical factors (visual experience and distressing experience). However, this latter four-factor part of the PES48 has thus far only been validated for the German version of the PES48. We investigated whether the overall eight-factor structure of the PES48 (which includes the MEQ30 four-factor structure) can also be validated, and thus potentially be put to good use in English.

methodsData from 280 English PES measurements (145 different healthy participants) from four placebo-controlled studies with low to high doses of psilocybin were included. The reliability of the eight subscales was evaluated using measures of internal consistency. The validity of the factor structure was assessed through model fit indices from confirmatory factor analysis. English results were then also compared with the German PES validation data set from Stocker et al. (2024).

resultsSix of the eight subscales (mystical, positive mood, transcendence of time and space, ineffability, connectedness, distressing experience) of the English PES48 show high internal consistency, one subscale (paradoxicality) shows good, and one (visual experience) acceptable internal consistency. Both MEQ models (MEQ30 and MEQ40) show similar fits (acceptable to good model fits). In English, both MEQ models show better fits than in German. All six MEQ40 scale means of the English data are higher compared to German data.

conclusionsThe findings suggest that the eight-factor PES48 is also a valid psychometric tool in English. With the MEQ40 part of the PES48, one can measure mystical experience with a still wider conceptual breath than with the MEQ30. Furthermore, one can also measure non-mystical visual and distressing states in an overall more comprehensive and broader conceptualization of the psychedelic experience. Higher MEQ40 scale means for the English than the German study participants could inspire future research into the role of setting in relation to mystical experience.

Indexed as

HallucinogensLysergic Acid DiethylamideMysticismPsilocybinPsychometricsAdultFactor Analysis, StatisticalFemaleHumansMaleReproducibility of ResultsSurveys and QuestionnairesYoung AdultHallucinogensLysergic Acid DiethylamidePsilocybinmystical experiencepsychedelic experiencepsychometricssetting

Identifiers

PMID42035466
PMCPMC13110837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.